Teva Pharmaceutical Industries Limited News Headlines

TEVA 
$60.15
*  
1.31
2.13%
Get TEVA Alerts
*Delayed - data as of May 6, 2015  -  Find a broker to begin trading TEVA now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By

Why Teva’s 1Q15 Revenues Declined Marginally
5/6/2015 7:26:00 PM - Market Realist


























Mylan Shareholders Well Placed in the Mylan–Teva Deal
4/30/2015 10:05:00 PM - Market Realist












Why Vivus Is Undervalued At Anything Under $10 Per Share
4/30/2015 8:38:00 AM - Seeking Alpha






Perrigo Rejects Mylan’s Increased Offer
4/29/2015 6:29:00 PM - Market Realist


The Perrigo–Mylan Proposal Faces some Big Hurdles
4/29/2015 6:03:00 PM - Market Realist


Mylan Launches Hostile Bid for Perrigo
4/29/2015 6:03:00 PM - Market Realist